Physician profile
Tena E Landers
NPI 1366887812
$7,418.23
in general payments reported to CMS, 2019-2025
54 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,364 · 2022: $1,441 · 2023: $1,427 · 2024: $1,494 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,613.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,187.24 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $995.63 | 2021-2025 | |
| Novo Nordisk INC | $746.39 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $412.65 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.09 | 2022-2024 | Jardiance, Ofev, Stiolto Respimat |
| Lilly USA, LLC | $249.45 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Teva Pharmaceuticals USA, INC. | $238.17 | 2021-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Glaxosmithkline, LLC. | $230.94 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Supernus Pharmaceuticals, INC. | $228.32 | 2021-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $222.82 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Bayer Healthcare Pharmaceuticals INC. | $185.89 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.11 | 2021-2024 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $134.63 | 2022-2025 | Eliquis, Camzyos |
| Otsuka America Pharmaceutical, INC. | $130.74 | 2022-2024 | Rexulti, Abilify Maintena |
| Astellas Pharma US INC | $130.44 | 2021-2025 | Veozah |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $126.47 | 2023-2024 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $121.22 | 2022-2024 | Jornay Pm |
| Jazz Pharmaceuticals INC. | $103.20 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $98.73 | 2025 | Jornay Pm |
| Daiichi Sankyo INC. | $93.25 | 2021-2024 | Injectafer |
| Amgen INC. | $89.28 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $86.03 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.24 | 2021-2023 | Trintellix |
| Lundbeck LLC | $82.36 | 2024-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $81.46 | 2022 | |
| Axsome Therapeutics, INC. | $79.36 | 2025 | Auvelity |
| Xeris Pharmaceuticals, INC. | $69.56 | 2023-2024 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $63.06 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $62.92 | 2021-2023 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.50 | 2022-2025 | Caplyta |
| Neos Therapeutics, LP | $49.19 | 2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Nestle Healthcare Nutrition INC. | $37.68 | 2021-2022 | |
| Inari Medical, INC. | $37.48 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kowa Pharmaceuticals America, INC. | $33.87 | 2022-2025 | Zoryve |
| Irhythm Technologies, INC. | $31.97 | 2024 | Zio Monitor, Zio Xt Patch |
| Idorsia Pharmaceuticals US INC | $30.63 | 2022-2023 | Quviviq |
| Organon LLC | $29.06 | 2025 | Nexplanon |
| Ibsa Pharma INC. | $28.90 | 2022-2023 | Tirosint, Licart |
| Zealand Pharma US, INC. | $23.47 | 2022 | |
| Noven Pharmaceuticals, INC. | $23.39 | 2024 | Xelstrym |
| Sage Therapeutics, LLC | $23.10 | 2023 | |
| Eisai INC. | $22.85 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $21.86 | 2025 | Opsumit |
| Sumitomo Pharma America, INC. | $21.27 | 2024 | Gemtesa |
| Cranial Technologies, INC | $20.95 | 2025 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $20.45 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $20.02 | 2023 | |
| Myovant Sciences INC. | $19.70 | 2022 | |
| Tris Pharma INC | $18.98 | 2023 | Dyanavel Xr |
| Corium, LLC | $18.68 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.30 | 2022 | |
| Esperion Therapeutics, INC. | $16.80 | 2021 | |
| Adlon Therapeutics L.P. | $15.65 | 2021 | |
| Baxter Healthcare | $14.83 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tena Landers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.